Skip to main content
Robert Soiffer, MD, Oncology, Boston, MA

RobertJSoifferMD

Oncology Boston, MA

Hematologic Oncology

Professor of Medicine, Dana-Farber Cancer Institute

Dr. Soiffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Soiffer's full profile

Already have an account?

  • Office

    44 Binney St
    # Dana
    Boston, MA 02115
    Phone+1 617-632-4731
    Fax+1 617-632-5175

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1986 - 1989
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1983 - 1986
  • New York University School of Medicine
    New York University School of MedicineClass of 1983

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - Present
  • MA State Medical License
    MA State Medical License 1986 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2010-2014
  • Boston Magazine Castle Connolly, 2009-2013
  • America's Top Doctors for Cancer Castle Connolly, 2009-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Small-Molecule BCL6 Inhibitor Effectively Treats Mice with Non-Sclerodermatous Chronic Graft-Versus-Host Disease  
    Joseph H Antin, Bruce Blazar, Leo Luznik, John Koreth, Ivan Maillard, Robert J Soiffer, James E Bradner, Jonathan S Serody, Jerome Ritz, Blood

Abstracts/Posters

  • Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Feasibility and Impact of Embedded Geriatric Consultation for Frail Older Adults with Blood Cancer: A Randomized Controlled Trial
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Improved Outcomes with Cyclophosphamide/Total Body Irradiation 14 Gy Compared to Cyclophosphamide/Total Body Irradiation 12 Gy in Patients with Acute Lymphoblastic Leu...
    Robert J. Soiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • BMT Peds and Adult 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Progression Risk-Based Classification of Asymptomatic Waldenström Macroglobulinemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B-Cell Lymphoma 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Study Finds Care After Donor Stem Cell Transplant Can Be Safely Shared Between Transplant Centers and Local Oncologists
    Study Finds Care After Donor Stem Cell Transplant Can Be Safely Shared Between Transplant Centers and Local OncologistsJanuary 9th, 2025
  • Gut Bacteria Engineered to Act as Tumor GPS for Immunotherapies
    Gut Bacteria Engineered to Act as Tumor GPS for ImmunotherapiesOctober 4th, 2024
  • New Research Offers Hope for Safer and More Effective Blood Stem Cell Transplants
    New Research Offers Hope for Safer and More Effective Blood Stem Cell TransplantsSeptember 4th, 2024
  • Join now to see all

Grant Support

  • Immune Modulation/Hematopoietic Cell TransplantationNational Institute Of Allergy And Infectious Diseases2005–2010
  • Induction Of Anti-Tumor Immunity After Allogeneic Hematopoietic Cell TransplantNational Institute Of Allergy And Infectious Diseases2007–2009
  • Induction Of Anti-Tumor Immunity After HC TransplantNational Institute Of Allergy And Infectious Diseases2005–2006
  • Administrative &Communications CoreNational Institute Of Allergy And Infectious Diseases2005
  • T Cell Infusions After Stem Cell TransplantationNational Institute Of Allergy And Infectious Diseases2000–2002
  • Immunologic Manipulation Of Donor Marrow PRE And Post Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1996–1998